Mn Services Vermogensbeheer B.V. Takes Position in Revvity, Inc. (NYSE:RVTY)

Mn Services Vermogensbeheer B.V. acquired a new stake in shares of Revvity, Inc. (NYSE:RVTYFree Report) during the fourth quarter, Holdings Channel reports. The firm acquired 58,000 shares of the company’s stock, valued at approximately $6,340,000.

Other hedge funds have also made changes to their positions in the company. Gladius Capital Management LP increased its stake in shares of Revvity by 84.1% during the third quarter. Gladius Capital Management LP now owns 232 shares of the company’s stock valued at $26,000 after acquiring an additional 106 shares during the period. CENTRAL TRUST Co acquired a new position in shares of Revvity during the fourth quarter valued at approximately $27,000. ORG Partners LLC acquired a new position in shares of Revvity during the fourth quarter valued at approximately $32,000. JTC Employer Solutions Trustee Ltd acquired a new position in shares of Revvity during the fourth quarter valued at approximately $33,000. Finally, Headinvest LLC acquired a new position in shares of Revvity during the third quarter valued at approximately $57,000. Institutional investors and hedge funds own 86.65% of the company’s stock.

Wall Street Analyst Weigh In

Several research analysts have issued reports on RVTY shares. Barclays lifted their price target on shares of Revvity from $92.00 to $105.00 and gave the stock an “equal weight” rating in a research report on Thursday, January 25th. UBS Group cut shares of Revvity from a “buy” rating to a “neutral” rating and lifted their price objective for the stock from $105.00 to $125.00 in a research report on Tuesday, January 16th. Evercore ISI raised shares of Revvity from an “in-line” rating to an “outperform” rating and lifted their target price for the company from $88.00 to $125.00 in a research note on Thursday, January 4th. Wells Fargo & Company started coverage on shares of Revvity in a research note on Tuesday, December 19th. They set an “equal weight” rating and a $95.00 target price for the company. Finally, Raymond James lifted their target price on shares of Revvity from $106.00 to $127.00 and gave the company an “outperform” rating in a research note on Friday, February 2nd. Six analysts have rated the stock with a hold rating and six have given a buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $118.91.

Get Our Latest Report on Revvity

Insider Transactions at Revvity

In other news, insider Prahlad R. Singh sold 21,217 shares of the business’s stock in a transaction dated Monday, February 5th. The shares were sold at an average price of $104.28, for a total transaction of $2,212,508.76. Following the transaction, the insider now owns 92,801 shares in the company, valued at approximately $9,677,288.28. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Insiders own 0.60% of the company’s stock.

Revvity Stock Down 1.1 %

Revvity stock opened at $102.33 on Tuesday. The firm has a market cap of $12.64 billion, a price-to-earnings ratio of 18.61, a P/E/G ratio of 2.69 and a beta of 1.09. The company has a debt-to-equity ratio of 0.40, a current ratio of 2.07 and a quick ratio of 1.77. Revvity, Inc. has a fifty-two week low of $79.50 and a fifty-two week high of $137.09. The firm has a fifty day moving average price of $105.04 and a two-hundred day moving average price of $101.79.

Revvity (NYSE:RVTYGet Free Report) last released its earnings results on Thursday, February 1st. The company reported $1.25 earnings per share for the quarter, topping analysts’ consensus estimates of $1.15 by $0.10. The firm had revenue of $695.90 million during the quarter. Revvity had a net margin of 25.20% and a return on equity of 7.41%. As a group, analysts forecast that Revvity, Inc. will post 4.65 earnings per share for the current year.

Revvity Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, May 10th. Stockholders of record on Friday, April 19th will be issued a dividend of $0.07 per share. The ex-dividend date is Thursday, April 18th. This represents a $0.28 annualized dividend and a dividend yield of 0.27%. Revvity’s payout ratio is 5.09%.

Revvity Company Profile

(Free Report)

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.

Featured Stories

Want to see what other hedge funds are holding RVTY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Revvity, Inc. (NYSE:RVTYFree Report).

Institutional Ownership by Quarter for Revvity (NYSE:RVTY)

Receive News & Ratings for Revvity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Revvity and related companies with MarketBeat.com's FREE daily email newsletter.